Allos Therapeutics Reports First Quarter 2010 Financial Results
Micrus Endovascular Corporation (Nasdaq: MEND) today reported financial results for the three and 12 months ended March 31, 2010 and introduced fiscal 2011 financial guidance. Highlights for the fiscal 2010 fourth quarter and full year include the …
Micrus Endovascular Corporation (Nasdaq: MEND) today reported financial results for the three and 12 months ended March 31, 2010 and introduced fiscal 2011 financial guidance. Highlights for the fiscal 2010 fourth quarter and full year include the …